BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31616982)

  • 1. 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.
    Saijo E; Metrick MA; Koga S; Parchi P; Litvan I; Spina S; Boxer A; Rojas JC; Galasko D; Kraus A; Rossi M; Newell K; Zanusso G; Grinberg LT; Seeley WW; Ghetti B; Dickson DW; Caughey B
    Acta Neuropathol; 2020 Jan; 139(1):63-77. PubMed ID: 31616982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid.
    Saijo E; Ghetti B; Zanusso G; Oblak A; Furman JL; Diamond MI; Kraus A; Caughey B
    Acta Neuropathol; 2017 May; 133(5):751-765. PubMed ID: 28293793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease.
    Kraus A; Saijo E; Metrick MA; Newell K; Sigurdson CJ; Zanusso G; Ghetti B; Caughey B
    Acta Neuropathol; 2019 Apr; 137(4):585-598. PubMed ID: 30570675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.
    Luk C; Compta Y; Magdalinou N; Martí MJ; Hondhamuni G; Zetterberg H; Blennow K; Constantinescu R; Pijnenburg Y; Mollenhauer B; Trenkwalder C; Van Swieten J; Chiu WZ; Borroni B; Cámara A; Cheshire P; Williams DR; Lees AJ; de Silva R
    J Neurochem; 2012 Nov; 123(3):396-405. PubMed ID: 22862741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases.
    Metrick MA; Ferreira NDC; Saijo E; Kraus A; Newell K; Zanusso G; Vendruscolo M; Ghetti B; Caughey B
    Acta Neuropathol Commun; 2020 Feb; 8(1):22. PubMed ID: 32087764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Metrick MA; Golbe LI; Santambrogio A; Kim M; Soto-Beasley AI; Walton RL; Baker MC; De Castro CF; DeTure M; Russell D; Navia BA; Sandiego C; Ross OA; Vendruscolo M; Caughey B; Dickson DW
    Acta Neuropathol Commun; 2023 Jun; 11(1):88. PubMed ID: 37264457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF tau microtubule-binding region identifies pathological changes in primary tauopathies.
    Horie K; Barthélemy NR; Spina S; VandeVrede L; He Y; Paterson RW; Wright BA; Day GS; Davis AA; Karch CM; Seeley WW; Perrin RJ; Koppisetti RK; Shaikh F; Lago AL; Heuer HW; Ghoshal N; Gabelle A; Miller BL; Boxer AL; Bateman RJ; Sato C
    Nat Med; 2022 Dec; 28(12):2547-2554. PubMed ID: 36424467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau seeds occur before earliest Alzheimer's changes and are prevalent across neurodegenerative diseases.
    Manca M; Standke HG; Browne DF; Huntley ML; Thomas OR; Orrú CD; Hughson AG; Kim Y; Zhang J; Tatsuoka C; Zhu X; Hiniker A; Coughlin DG; Galasko D; Kraus A
    Acta Neuropathol; 2023 Jul; 146(1):31-50. PubMed ID: 37154939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
    Dickson DW; Kouri N; Murray ME; Josephs KA
    J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes.
    Lleó A; Irwin DJ; Illán-Gala I; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    JAMA Neurol; 2018 Jun; 75(6):738-745. PubMed ID: 29554190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration.
    Cousins KAQ; Irwin DJ; Wolk DA; Lee EB; Shaw LMJ; Trojanowski JQ; Da Re F; Gibbons GS; Grossman M; Phillips JS
    Brain; 2020 Jul; 143(7):2295-2311. PubMed ID: 32666090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
    Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
    Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
    Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
    Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
    Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
    Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seeding Activity of Skin Misfolded Tau as a Biomarker for Tauopathies.
    Wang Z; Wu L; Gerasimenko M; Gilliland T; Gunzler SA; Donadio V; Liguori R; Xu B; Zou WQ
    Res Sq; 2024 Mar; ():. PubMed ID: 38496453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
    Irwin DJ; Lleó A; Xie SX; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
    Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
    Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
    Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.